1. Home
  2. PRLD vs PZG Comparison

PRLD vs PZG Comparison

Compare PRLD & PZG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRLD
  • PZG
  • Stock Information
  • Founded
  • PRLD 2016
  • PZG 1992
  • Country
  • PRLD United States
  • PZG United States
  • Employees
  • PRLD N/A
  • PZG N/A
  • Industry
  • PRLD Medicinal Chemicals and Botanical Products
  • PZG Metal Mining
  • Sector
  • PRLD Health Care
  • PZG Basic Materials
  • Exchange
  • PRLD Nasdaq
  • PZG Nasdaq
  • Market Cap
  • PRLD 44.0M
  • PZG 48.4M
  • IPO Year
  • PRLD 2020
  • PZG 1999
  • Fundamental
  • Price
  • PRLD $1.19
  • PZG $1.05
  • Analyst Decision
  • PRLD Strong Buy
  • PZG
  • Analyst Count
  • PRLD 3
  • PZG 0
  • Target Price
  • PRLD $4.00
  • PZG N/A
  • AVG Volume (30 Days)
  • PRLD 223.1K
  • PZG 917.2K
  • Earning Date
  • PRLD 11-05-2025
  • PZG 09-25-2025
  • Dividend Yield
  • PRLD N/A
  • PZG N/A
  • EPS Growth
  • PRLD N/A
  • PZG N/A
  • EPS
  • PRLD N/A
  • PZG N/A
  • Revenue
  • PRLD $7,000,000.00
  • PZG N/A
  • Revenue This Year
  • PRLD N/A
  • PZG N/A
  • Revenue Next Year
  • PRLD N/A
  • PZG N/A
  • P/E Ratio
  • PRLD N/A
  • PZG N/A
  • Revenue Growth
  • PRLD N/A
  • PZG N/A
  • 52 Week Low
  • PRLD $0.61
  • PZG $0.31
  • 52 Week High
  • PRLD $5.53
  • PZG $1.20
  • Technical
  • Relative Strength Index (RSI)
  • PRLD 56.86
  • PZG 79.60
  • Support Level
  • PRLD $1.10
  • PZG $1.00
  • Resistance Level
  • PRLD $1.26
  • PZG $1.10
  • Average True Range (ATR)
  • PRLD 0.15
  • PZG 0.07
  • MACD
  • PRLD -0.00
  • PZG 0.01
  • Stochastic Oscillator
  • PRLD 70.65
  • PZG 67.53

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.

About PZG Paramount Gold Nevada Corp.

Paramount Gold Nevada Corp is an exploration-stage mining company. Together with its subsidiaries, the company is engaged in the business of acquiring, exploring, and developing precious metal projects in the United States. Also, it explores for gold and silver. The company enhances the value of projects by implementing exploration and engineering programs that are likely to expand and upgrade known mineralized material to reserves. Its projects include sleeper gold, grassy mountain gold, frost project, other non-material, and others.

Share on Social Networks: